mRNA Cancer vaccines: construction and boosting strategies
In late 2020, the US Food and Drug Administration (FDA) approved a lipid-based mRNA
vaccine for the prevention of COVID-19, which has pushed this field to be more closely …
vaccine for the prevention of COVID-19, which has pushed this field to be more closely …
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
Simple Summary Cancer treatments have made remarkable advances with the introduction
of immunotherapy, which recruits the body's immune system to fight cancer. Despite these …
of immunotherapy, which recruits the body's immune system to fight cancer. Despite these …
Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of …
In the realm of cancer immunotherapy, a profound evolution has ushered in sophisticated
strategies that encompass both traditional cancer vaccines and emerging viral vaccines …
strategies that encompass both traditional cancer vaccines and emerging viral vaccines …
Overcoming suppressive tumor microenvironment by vaccines in solid tumor
Conventional vaccines are widely used to boost human natural ability to defend against
foreign invaders, such as bacteria and viruses. Recently, therapeutic cancer vaccines …
foreign invaders, such as bacteria and viruses. Recently, therapeutic cancer vaccines …
Harnessing biomaterial architecture to drive anticancer innate immunity
MA Davis, E Cho, MH Teplensky - Journal of Materials Chemistry B, 2023 - pubs.rsc.org
Immunomodulation is a powerful therapeutic approach that harnesses the body's own
immune system and reprograms it to treat diseases, such as cancer. Innate immunity is key …
immune system and reprograms it to treat diseases, such as cancer. Innate immunity is key …
Components, Formulations, Deliveries, and Combinations of Tumor Vaccines
T Liu, W Yao, W Sun, Y Yuan, C Liu, X Liu, X Wang… - ACS …, 2024 - ACS Publications
Tumor vaccines, an important part of immunotherapy, prevent cancer or kill existing tumor
cells by activating or restoring the body's own immune system. Currently, various …
cells by activating or restoring the body's own immune system. Currently, various …
Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach
Abstract mRNA vaccines have long been recognized for their ability to induce robust
immune responses. The discovery that mRNA vaccines may also contribute to antitumor …
immune responses. The discovery that mRNA vaccines may also contribute to antitumor …
Modification with Conventional Surfactants to Improve a Lipid-Based Ionic-Liquid-Associated Transcutaneous Anticancer Vaccine
Transcutaneous vaccination is one of the successful, affordable, and patient-friendly
advanced immunization approaches because of the presence of multiple immune …
advanced immunization approaches because of the presence of multiple immune …
Targeting Neoantigens in Pancreatic Ductal Adenocarcinoma
G Singh, D Kutcher, R Lally, V Rai - Cancers, 2024 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of
cancer deaths in the United States due to its late-stage diagnosis. Currently, there are no …
cancer deaths in the United States due to its late-stage diagnosis. Currently, there are no …
Exosome-like Systems: From Therapies to Vaccination for Cancer Treatment and Prevention—Exploring the State of the Art
HH Sheikhhossein, F Iommelli, N Di Pietro, MC Curia… - Vaccines, 2024 - mdpi.com
Cancer remains one of the main causes of death in the world due to its increasing incidence
and treatment difficulties. Although significant progress has been made in this field …
and treatment difficulties. Although significant progress has been made in this field …